• Profile
Close

The prognostic impact of primary tumor location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomized trials

European Journal of Cancer Mar 28, 2019

Cascinu S, et al. - Investigators studied 5,239 patients to assess the prognostic consequence of primary tumor location in outpatients with stage II and stage III colon cancer receiving adjuvant treatment. They observed 1,540 right-sided tumors, 815 tumors originating in the transverse, and, 2,884 left-sided tumors. They found that DFS findings from the right-sided vs left-sided tumors were not statistically correlated with clinical consequences in the overall population, but outcomes were significantly associated with overall survival (OS) of the right-sided vs left-sided tumors. In stage II cases, they found no variation in terms of DFS and OS among the three separate tumor locations, but left-sided tumors had an improved prognosis in terms of OS in stage III cases.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay